Breaking News, Collaborations & Alliances

Fujifilm Diosynth Biotechnologies Begins COVID-19 Vax Production

Texas A&M System contract designates the CDMO’s Texas facility for emergency federal use.

By: Contract Pharma

Contract Pharma Staff

Fujifilm Diosynth Biotechnologies, and the Texas A&M University System Center for Innovation in Advanced Development & Manufacturing (CIADM), have begun production on two different COVID-19 vaccine candidates with support from the U.S. government to meet Operation Warp Speed goals.   Fujifilm Diosynth Biotechnologies Texas, a subcontractor of the CIADM, recently completed its capacity expansion at its Flexible Biomanufacturing Facility in College Station, TX, to accommodate large-scale...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters